- Home
- Africa Point Of Care Diagnostics Market
Africa Point-of-Care Diagnostics Market- Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-329 | No of pages: 208 | Format:
Africa point-of-care diagnostics market is projected to grow at a CAGR of 5.7% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation:
Africa Point-Of-Care Diagnostics Market, By Type (Devices, Consumables and Kits, Software and Services, Accessories), Platform (Lateral Flow Assays /Immunochromatography Tests, Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Sales), Country (Kenya, Algeria, Nigeria, Morocco, Rwanda, Zambia, Uganda, Central African Republic, Chad, Ethiopia, Mauritania, Cameroon, Angola, Libya, DRC, Ghana, Malawi) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of Africa point-of-care diagnostics market are:
Rising geriatric population
Rising preference for homecare testing
Market Players:
The key market players for Africa point-of-care diagnostics market are listed below:
BioTech Africa
Medtronic
Bio-Rad Laboratories, Inc.
PTS Diagnostics
Trinity Biotech
Atlas Medical Uk
Abbott
Sysmex Corporation
bioMrieux SA
Quidel Corporation
BD
Sekisui Diagnostics
F. Hoffmann-La Roche Ltd
Beckman Coulter, Inc.
ACON Laboratories, Inc.
Nova Biomedical
Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG)
Instrumentation Laboratory
Abaxis
Radiometer Medical ApS (a subsidiary of Danaher)
TABLE OF CONTENT
TABLE OF CONTENTS 1 INTRODUCTION 20 1.1 OBJECTIVES OF THE STUDY 20 1.2 MARKET DEFINITION 20 1.3 OVERVIEW OF AFRICA POINT-OF-CARE DIAGNOSTICS MARKET 20 1.4 LIMITATIONS 21 1.5 MARKETS COVERED 22 2 MARKET SEGMENTATION 24 2.1 MARKETS COVERED 24 2.2 GEOGRAPHICAL SCOPE 25 2.3 YEARS CONSIDERED FOR THE STUDY 26 2.4 CURRENCY AND PRICING 26 2.5 DBMR TRIPOD DATA VALIDATION MODEL 27 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 30 2.7 MULTIVARIATE MODELLING 31 2.8 DISTRIBUTION CHANNEL LIFELINE CURVE 31 2.9 DBMR MARKET POSITION GRID 32 2.10 VENDOR SHARE ANALYSIS 33 2.11 SECONDARY SOURCES 34 2.12 ASSUMPTIONS 34 3 EXECUTIVE SUMMARY 35 4 PREMIUM INSIGHTS 37 5 MARKET OVERVIEW 38 5.1 DRIVERS 40 5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 40 5.1.2 IMPROVING DIAGNOSIS SEEKING RATE 41 5.1.3 GROWING POPULARITY OF WEARABLE AND PORTABLE GLUCOSE MONITORING DEVICES 42 5.1.4 RISING PREFERENCE FOR HOMECARE TESTING 42 5.2 RESTRAINTS 43 5.2.1 PRODUCT RECALLS 43 5.2.2 HIGH COSTS OF PRODUCTS 43 5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS 43 5.3 OPPORTUNITIES 44 5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS 44 5.3.2 RISING HEALTHCARE EXPENDITURE 45 5.3.3 TECHNOLOGICAL ADVANCEMENTS IN POINT-OF-CARE TESTING DEVICES 45 5.4 CHALLENGE 46 5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES 46 6 IMPACT OF COVID-19 ON THE AFRICA POINT-OF-CARE DIAGNOSTICS MARKET 47 6.1 IMPACT ON PRICE 47 6.2 IMPACT ON DEMAND 47 6.3 IMPACT ON SUPPLY CHAIN 47 6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19 48 6.5 CONCLUSION: 48 7 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE 49 7.1 OVERVIEW 50 7.2 DEVICES 53 7.2.1 HEALTHCARE-ASSOCIATED INFECTION (HAI) 54 7.2.1.1 Respiratory infection 55 7.2.1.2 Tropical disease 55 7.2.1.3 Other infectious disease 55 7.2.2 HEMATOLOGY 55 7.2.3 CARDIAC MARKER ANALYZERS 55 7.2.4 URINALYSIS 55 7.2.5 COAGULATION 55 7.2.6 PREGNANCY AND FERTILITY 55 7.2.7 HIV 55 7.2.8 GLUCOSE MONITORING PRODUCTS 55 7.2.9 INFLUENZA 55 7.2.10 FECAL OCCULT 56 7.2.11 HEPATITIS 56 7.2.12 DRUGS-OF-ABUSE 56 7.2.13 SEXUALLY TRANSMITTED DISEASE (STD) 56 7.2.14 CHOLESTEROL 56 7.2.15 TUMOR/CANCER MARKER 56 7.2.16 OTHER POC PRODUCTS 56 7.3 CONSUMABLES AND KITS 56 7.3.1 GLUCOSE MONITORING STRIPS 57 7.3.2 HIV TEST KIT 57 7.3.3 LANCETS AND LANCET SYSTEMS 57 7.3.4 CHOLESTEROL TEST KITS 57 7.3.5 PREGNANCY TEST KITS 57 7.3.6 FERTILITY TEST KITS 57 7.3.7 OTHERS 58 7.4 SOFTWARE AND SERVICES 58 7.5 ACCESSORIES 58 8 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM 59 8.1 OVERVIEW 60 8.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS 63 8.3 MOLECULAR DIAGNOSTICS 63 8.4 IMMUNOASSAYS 63 8.5 DIPSTICKS 64 8.6 MICROFLUIDICS 64 9 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER 65 9.1 OVERVIEW 66 9.2 PROFESSIONAL DIAGNOSTIC CENTERS 69 9.2.1 HOSPITALS/CRITICAL CARE CENTERS 69 9.2.2 CLINICAL LABORATORIES, OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS 69 9.3 HOME CARE 69 9.4 RESEARCH LABORATORIES 70 9.5 OTHER END USERS 70 10 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 71 10.1 OVERVIEW 72 10.2 DIRECT TENDERS 75 10.3 RETAIL SALES 75 11 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET 76 11.1 AFRICA 76 11.1.1 KENYA 83 11.1.2 ALGERIA 86 11.1.3 NIGERIA 90 11.1.4 MOROCCO 94 11.1.5 RWANDA 98 11.1.6 ZAMBIA 102 11.1.7 UGANDA 106 11.1.8 CENTRAL AFRICAN REPUBLIC 110 11.1.9 CHAD 114 11.1.10 ETHIOPIA 118 11.1.11 MAURITANIA 122 11.1.12 CAMEROON 126 11.1.13 ANGOLA 130 11.1.14 LIBYA 134 11.1.15 DRC 138 11.1.16 GHANA 142 11.1.17 MALAWI 146 12 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: COMPANY LANDSCAPE 150 12.1 COMPANY SHARE ANALYSIS: AFRICA 150 13 SWOT ANALYSIS 151 14 COMPNYA PROFILE 152 14.1 F. HOFFMANN-LA ROCHE LTD 152 14.1.1 COMPANY SNAPSHOT 152 14.1.2 REVENUE ANALYSIS 152 14.1.3 PRODUCT PORTFOLIO 153 14.1.4 RECENT DEVELOPMENTS 154 14.2 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG) 155 14.2.1 COMPANY SNAPSHOT 155 14.2.2 REVENUE ANALYSIS 155 14.2.3 PRODUCT PORTFOLIO 155 14.2.4 RECENT DEVELOPMENTS 157 14.3 BECKMAN COULTER, INC. 158 14.3.1 COMPANY SNAPSHOT 158 14.3.2 PRODUCT PORTFOLIO 158 14.3.3 RECENT DEVELOPMENTS 158 14.4 BD 160 14.4.1 COMPANY SNAPSHOT 160 14.4.2 REVENUE ANALYSIS 160 14.4.3 PRODUCT PORTFOLIO 161 14.4.4 RECENT DEVELOPMENTS 161 14.5 BIOMRIEUX SA 162 14.5.1 COMPANY SNAPSHOT 162 14.5.2 REVENUE ANALYSIS 162 14.5.3 PRODUCT PORTFOLIO 163 14.5.4 RECENT DEVELOPMENT 163 14.6 ABBOTT 164 14.6.1 COMPANY SNAPSHOT 164 14.6.2 REVENUE ANALYSIS 164 14.6.3 PRODUCT PORTFOLIO 165 14.6.4 RECENT DEVELOPMENTS 165 14.7 ABAXIS 167 14.7.1 COMPANY SNAPSHOT 167 14.7.2 PRODUCT PORTFOLIO 167 14.7.3 RECENT DEVELOPMENTS 168 14.8 ACON LABORATORIES, INC. 169 14.8.1 COMPANY SNAPSHOT 169 14.8.2 PRODUCT PORTFOLIO 170 14.8.3 RECENT DEVELOPMENTS 170 14.9 ATLAS MEDICAL UK 172 14.9.1 COMPANY SNAPSHOT 172 14.9.2 PRODUCT PORTFOLIO 172 14.9.3 RECENT DEVELOPMENTS 174 14.10 BIOTECH AFRICA 176 14.10.1 COMPANY SNAPSHOT 176 14.10.2 PRODUCT PORTFOLIO 176 14.10.3 RECENT DEVELOPMENT 177 14.11 BIO-RAD LABORATORIES, INC. 178 14.11.1 COMPANY SNAPSHOT 178 14.11.2 REVENUE ANALYSIS 178 14.11.3 PRODUCT PORTFOLIO 179 14.11.4 RECENT DEVELOPMENT 180 14.12 INSTRUMENTATION LABORATORY 181 14.12.1 COMPANY SNAPSHOT 181 14.12.2 PRODUCT PORTFOLIO 181 14.12.3 RECENT DEVELOPMENTS 182 14.13 MEDTRONIC 183 14.13.1 COMPANY SNAPSHOT 183 14.13.2 REVENUE ANALYSIS 184 14.13.3 PRODUCT PORTFOLIO 184 14.13.4 RECENT DEVELOPMENTS 185 14.14 NOVA BIOMEDICAL 186 14.14.1 COMPANY SNAPSHOT 186 14.14.2 PRODUCT PORTFOLIO 186 14.14.3 RECENT DEVELOPMENTS 187 14.15 PTS DIAGNOSTICS 189 14.15.1 COMPANY SNAPSHOT 189 14.15.2 PRODUCT PORTFOLIO 189 14.15.3 RECENT DEVELOPMENTS 190 14.16 RADIOMETER MEDICAL APS (A SUBSIDIARY OF DANAHER) 191 14.16.1 COMPANY SNAPSHOT 191 14.16.1 REVENUE ANALYSIS 191 14.16.2 PRODUCT PORTFOLIO 191 14.16.3 RECENT DEVELOPMENTS 192 14.17 SEKISUI DIAGNOSTICS 193 14.17.1 COMPANY SNAPSHOT 193 14.17.2 PRODUCT PORTFOLIO 193 14.17.3 RECENT DEVELOPMENT 194 14.18 SYSMEX CORPORATION 195 14.18.1 COMPANY SNAPSHOT 195 14.18.2 REVENUE ANALYSIS 195 14.18.3 PRODUCT PORTFOLIO 196 14.18.4 RECENT DEVELOPMENT 197 14.19 TRINITY BIOTECH 198 14.19.1 COMPANY SNAPSHOT 198 14.19.2 REVENUE ANALYSIS 198 14.19.3 PRODUCT PORTFOLIO 199 14.19.4 RECENT DEVELOPMENTS 199 14.20 QUIDEL CORPORATION 201 14.20.1 COMPANY SNAPSHOT 201 14.20.2 REVENUE ANALYSIS 201 14.20.3 PRODUCT PORTFOLIO 202 14.20.4 RECENT DEVELOPMENTS 202 15 QUESTIONNAIRE 205 16 RELATED REPORTS 208Segmentation
Short Description Africa Point-Of-Care Diagnostics Market, By Type (Devices, Consumables and Kits, Software and Services, Accessories), Platform (Lateral Flow Assays /Immunochromatography Tests, Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Sales), Country (Kenya, Algeria, Nigeria, Morocco, Rwanda, Zambia, Uganda, Central African Republic, Chad, Ethiopia, Mauritania, Cameroon, Angola, Libya, DRC, Ghana, Malawi) Industry Trends and Forecast to 2028 Market Definition: The Point-of-care diagnostics is categorized as a testing which can be done in close vicinity to the patient where a medical decision can be made immediately including the results and monitoring. Point-of-care diagnostics is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within less than minutes as compared to hours. It ensures patients to receive the most effective and efficient care when and wherever needed. Additionally, Point-of-care diagnostics enables staff to make rapid decisions of treatments when diagnosing patients condition and the Point-of-care diagnostics simplifying the testing process. Market Segmentation: The Point-of-care diagnostics market is segmented on the basis of type, platform, end user and distribution channel. On the basis of type, the Point-of-care diagnostics market is segmented into devices, software and services, consumables and kits, and accessories. On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics, immunoassays. On the basis of end user, the point-of-care diagnostics market is segmented into professional diagnostic centers, home care, research laboratories and other end users. On the basis of distribution channel, the point-of-care diagnostics market is segmented into direct tender and retail sales. Market Players The major players in Africa Point-of-care diagnostics market are: BioTech Africa Medtronic Bio-Rad Laboratories, Inc. PTS Diagnostics Trinity Biotech Atlas Medical Uk Abbott Sysmex Corporation bioMrieux SA Quidel Corporation BD Sekisui Diagnostics F. Hoffmann-La Roche Ltd Beckman Coulter, Inc. ACON Laboratories, Inc. Nova Biomedical Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG) Instrumentation Laboratory Abaxis Radiometer Medical ApS (a subsidiary of Danaher)Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.